Published by Michele Maatouk on 6th January 2026
(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.
URL: http://www.digitallook.com/dl/news/story/35611720/...